ArticleJournal of oncology2021

A Comprehensive Multiomics Analysis Identified Ubiquilin 4 as a Promising Prognostic Biomarker of Immune-Related Therapy in Pan-Cancer.

Jie Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.